4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-016362
Options or other derivatives
- Director acquired 171,792 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
STALDER RUEDI · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2010-11-17 | Grant or award : show line 1 in the form Common Stock Option | +71,792 | $0.26 | 2020-11-17 | 71,792 | 981,743 | D |
| 2010-11-17 | Grant or award : show line 2 in the form Common Stock Option | +100,000 | $0.26 | 2020-11-17 | 100,000 | 1,081,743 | D |
Loading xslF345X03/edgar.xml…